Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The AMD topic and related MedlinePlus Genetics topics were removed from the page content. This reduces the page’s contextual references to AMD and associated resources.
    Difference
    0.2%
    Check dated 2026-01-21T00:02:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page adds the topic 'Age-related macular degeneration', adds a related topic 'MedlinePlus Genetics', and updates the revision tag from v3.3.3 to v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-14T02:00:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The disease term 'Age-related macular degeneration' and the related topic 'MedlinePlus Genetics' were removed from the page's topics.
    Difference
    0.2%
    Check dated 2026-01-07T00:55:21.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now includes an updated Locations section listing Maryland as a study site. The footer/navigation changes remove the HHS Vulnerability Disclosure link and the Maryland Locations heading, with the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T20:32:12.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; this update appears to be a metadata/backend change with no impact on study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T22:01:09.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding notice that warned about potential data delays and limited responses on the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T20:08:49.000Z thumbnail image

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.